Skip to main content

Advertisement

Table 2 Probability of recurrence of patients from the two trial arms, sorted by tumour size, at different follow-up times (95% confidence intervals in parenthesis)

From: Comparative benefit from small tumour size and adjuvant chemotherapy: clues for explaining breast cancer mortality decline

  Years of follow-up
5 10 15
Controls, T1 0.46 (0.38-0.54) 0.61 (0.52-0.69) 0.67 (0.59-0.75)
Controls, T2/T3 0.62 (0.53-0.70) 0.72 (0.64-0.80) 0.76 (0.67-0.83)
CMF, T1 0.38 (0.30-0.46) 0.51 (0.42-0.59) 0.59 (0.50-0.67)
CMF, T2/T3 0.46 (0.38-0.55) 0.57 (0.49-0.65) 0.62 (0.54-0.70)